Description
EMPIGET M 5/1000mg, supplied in a convenient pack of 28 tablets, offers a powerful dual-action therapy for adults managing type 2 diabetes. Each tablet combines Empagliflozin 5mg, an SGLT2 inhibitor that aids kidneys in excreting excess glucose, with Metformin Hydrochloride 1000mg, which reduces glucose production and enhances insulin sensitivity. This synergistic combination effectively lowers blood sugar levels. Beyond glycemic control, EMPIGET M 5/1000mg also provides significant benefits by reducing the risk of cardiovascular death, hospitalization for heart failure, and the progression of chronic kidney disease in eligible patients. Used as an adjunct to diet and exercise, it offers comprehensive support for long-term diabetes management and improved overall health.
